MBX Biosciences, Inc. MBX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$23.52M-6.6% | -$22.06M-2.1% | -$21.62M-11.4% | -$19.41M+18.7% | -$23.88M-53.2% | ||
| $64K+6.7% | $60K-40.0% | $100K0.0% | $100K+29.9% | $77K+32.8% | ||
| $5.48M+106% | $2.66M+18.3% | $2.25M+15.9% | $1.94M+5.3% | $1.84M+23.6% | ||
| $3.97M+561% | -$861K+57.8% | -$2.04M-202% | $2.01M+229% | -$1.56M-342% | ||
| -$4.86M-209% | $4.45M+118% | $2.04M— | $0-100% | $558K— | ||
| $725K-63.8% | $2.01M+29.8% | $1.55M+94.3% | $795K+148% | -$1.65M-260% | ||
| -$41K— | —— | —— | $521K+1,340% | -$42K-5.0% | ||
| -$20.21M-10.4% | -$18.3M+15.0% | -$21.54M-23.5% | -$17.43M+23.1% | -$22.68M-41.4% | ||
| $437K-44.9% | $793K+98.7% | $399K-43.6% | $707K+2,257% | $30K-67.4% | ||
| -$97.1M+25.3% | -$129.97M-862% | $17.06M-34.4% | $25.99M+706% | $3.23M+105% | ||
| $2.44M+156% | $955K+635% | $130K-90.2% | $1.33M+33,050% | $4K-97.9% | ||
| $87.44M+19,862% | $438K-99.8% | $187.82M+14,065% | $1.33M+33,050% | $4K— | ||
| -$29.87M— | —— | $183.34M— | —— | -$19.45M— | ||
| $579K+4.3% | $555K-24.4% | $734K-25.0% | $979K-27.1% | $1.34M-3.9% | ||
| $64K+6.7% | $60K-40.0% | $100K0.0% | $100K+29.9% | $77K+32.8% | ||
| -$41K— | —— | —— | $521K+1,340% | -$42K-5.0% | ||
| $43K— | —— | —— | —— | $0— | ||
| $725K-63.8% | $2.01M+29.8% | $1.55M+94.3% | $795K+148% | -$1.65M-260% | ||
| $34K+6.3% | $32K0.0% | $32K-20.0% | $40K+37.9% | $29K+7.4% | ||
| $378K-26.9% | $517K+104% | $254K— | $0— | $0-100% | ||
| —— | $0— | —— | —— | —— | ||
| $24K+14.3% | $21K— | —— | —— | $502K+3,762% | ||
| $106K— | —— | —— | —— | $0— | ||
| -$41K— | —— | —— | $521K+1,340% | -$42K-5.0% | ||
| $2K— | —— | $7K-12.5% | $8K-57.9% | $19K— | ||
| -$20.65M-8.1% | -$19.09M+13.0% | -$21.94M-20.9% | -$18.14M+20.1% | -$22.71M-40.8% | ||
| -$20.65M-8.1% | -$19.09M+13.0% | -$21.94M-20.9% | -$18.14M+20.1% | -$22.71M-40.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does MBX Biosciences, Inc.'s cash flow data come from?
- Every line is extracted from MBX Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.